questionnaires to collect patient reported outcomes clinical trials

Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers

This study aims to understand why some cancer treatments, called ADCs, stop working. By looking at samples from patients with advanced breast, stomach, bladder, or lung cancer, researchers hope to find better ways to choose the right ADC for each person and reduce side effects.